Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials. [PDF]
CureusSelvaraj V.
europepmc +1 more source
CD26 as a potential therapeutic target for lung adenocarcinoma. [PDF]
Front OncolJungraithmayr W +10 more
europepmc +1 more source
Development and Validation of High-Performance Thin Layer Chromatographic Method for the Simultaneous Estimation of Dapagliflozin and Vildagliptin in Fixed-Dose Combination. [PDF]
Turk J Pharm SciKrishnamoorthy YV +2 more
europepmc +1 more source
<i>In Vivo</i> and <i>In Silico</i> Analysis of Quercetin's Effects on Glycemic Regulation. [PDF]
Scientifica (Cairo)Jumriani J +11 more
europepmc +1 more source
Therapeutic impact of vildagliptin vs. gliclazide on insulin resistance and advanced glycated end product levels in newly diagnosed Egyptian diabetics: a randomized controlled trial. [PDF]
Eur J Clin PharmacolElemary T +3 more
europepmc +1 more source
Vildagliptin modulates the microbiota and induces an immunometabolic profile compatible with neuroprotection in type 2 diabetes. [PDF]
Sci Repde Macedo JCC +9 more
europepmc +1 more source
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers [PDF]
, 2016 Matthew Taylor, William Green
core +1 more source
The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy. [PDF]
Front Endocrinol (Lausanne)Kong D +7 more
europepmc +1 more source